用于慢性阻塞性肺疾病的茶碱
Theophylline for COPD.
作者信息
Barnes P J
出版信息
Thorax. 2006 Sep;61(9):742-4. doi: 10.1136/thx.2006.061002.
Abstract
Reinstatement in the light of new evidence?
摘要
鉴于新证据而恢复？
相似文献
1
Theophylline for COPD.用于慢性阻塞性肺疾病的茶碱
Thorax. 2006 Sep;61(9):742-4. doi: 10.1136/thx.2006.061002.
2
3
Theophylline in chronic obstructive pulmonary disease: new horizons.慢性阻塞性肺疾病中的茶碱：新视野
Proc Am Thorac Soc. 2005;2(4):334-9; discussion 340-1. doi: 10.1513/pats.200504-024SR.
4
[Development of theophylline in treatment of asthma and chronic obstructive pulmonary disease].[茶碱在哮喘和慢性阻塞性肺疾病治疗中的发展]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Jun;26(3):319-22.
5
[When beta-mimetic and anticholinergic agents fail in COPD. More air with theophylline].[当β受体激动剂和抗胆碱能药物对慢性阻塞性肺疾病无效时。茶碱带来更多通气]
MMW Fortschr Med. 2004 Apr 29;146(18):57.
6
Theophylline: new perspectives for an old drug.茶碱：一种老药的新视角。
Am J Respir Crit Care Med. 2003 Mar 15;167(6):813-8. doi: 10.1164/rccm.200210-1142PP.
7
Acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重
N Engl J Med. 2002 Nov 7;347(19):1533-4; author reply 1533-4. doi: 10.1056/NEJM200211073471919.
8
Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.接受含茶碱药物治疗方案的慢性阻塞性肺疾病患者的死亡风险。
Pharmacotherapy. 2009 Sep;29(9):1039-53. doi: 10.1592/phco.29.9.1039.
9
[Longterm treatment of COPD with theophylline--still a valuable option?].[使用茶碱对慢性阻塞性肺疾病进行长期治疗——仍是一个有价值的选择？]
Pneumologie. 2003 Oct;57(10):598-605. doi: 10.1055/s-2003-43022.
10
Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies.慢性阻塞性肺疾病治疗的新趋势：支气管扩张剂的单一疗法和联合疗法
Drug Discov Today. 2007 Jun;12(11-12):472-8. doi: 10.1016/j.drudis.2007.04.003. Epub 2007 Apr 26.
引用本文的文献
1
Analysis of network expression and immune infiltration of disulfidptosis-related genes in chronic obstructive pulmonary disease.分析慢性阻塞性肺疾病中二硫键相关基因的网络表达和免疫浸润。
Immun Inflamm Dis. 2024 Apr;12(4):e1231. doi: 10.1002/iid3.1231.
2
Verproside, the Most Active Ingredient in YPL-001 Isolated from var. , Decreases Inflammatory Response by Inhibiting PKCδ Activation in Human Lung Epithelial Cells.从 var. 中分离出的 YPL-001 的最有效成分——普罗雌烯，通过抑制蛋白激酶 Cδ 的激活来降低人肺上皮细胞的炎症反应。
Int J Mol Sci. 2023 Apr 13;24(8):7229. doi: 10.3390/ijms24087229.
3
COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort: a study to explore preventable hospitalisation.COPD 疾病知识、自我意识以及主要为澳大利亚原住民队列的住院原因：一项探索可预防住院的研究。
BMJ Open Respir Res. 2022 Aug;9(1). doi: 10.1136/bmjresp-2022-001295.
4
2-Cl-C.OXT-A stimulates contraction through the suppression of phosphodiesterase activity in human induced pluripotent stem cell-derived cardiac organoids.2-Cl-C.OXT-A 通过抑制人诱导多能干细胞衍生的心脏类器官中的磷酸二酯酶活性来刺激收缩。
PLoS One. 2019 Jul 11;14(7):e0213114. doi: 10.1371/journal.pone.0213114. eCollection 2019.
5
Systemic Inflammation in the Genesis of Frailty and Sarcopenia: An Overview of the Preventative and Therapeutic Role of Exercise and the Potential for Drug Treatments.衰弱和肌肉减少症发生过程中的全身炎症：运动的预防和治疗作用及药物治疗潜力概述
Geriatrics (Basel). 2017 Jan 17;2(1):6. doi: 10.3390/geriatrics2010006.
6
Steroid Resistant CD8CD28 NKT-Like Pro-inflammatory Cytotoxic Cells in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中类固醇抵抗性CD8CD28自然杀伤T细胞样促炎细胞毒性细胞
Front Immunol. 2016 Dec 19;7:617. doi: 10.3389/fimmu.2016.00617. eCollection 2016.
7
Theophylline.茶碱
Pharmaceuticals (Basel). 2010 Mar 18;3(3):725-747. doi: 10.3390/ph3030725.
8
Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks.甲基黄嘌呤的结构-生物活性关系：试图厘清所有的前景与不足。
Molecules. 2016 Jul 27;21(8):974. doi: 10.3390/molecules21080974.
9
Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease.嗜酸性气道炎症：在哮喘和慢性阻塞性肺疾病中的作用
Ther Adv Chronic Dis. 2016 Jan;7(1):34-51. doi: 10.1177/2040622315609251.
10
The Study of Efficacy, Tolerability and Safety of Theophylline Given Along with Formoterol Plus Budesonide in COPD.在慢性阻塞性肺疾病（COPD）中，与福莫特罗加布地奈德联合使用时茶碱的疗效、耐受性和安全性研究。
J Clin Diagn Res. 2015 Feb;9(2):OC10-3. doi: 10.7860/JCDR/2015/10803.5527. Epub 2015 Feb 1.
本文引用的文献
1
Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline.慢性阻塞性肺疾病气道中活性氮物质生成的抑制：吸入性糖皮质激素与口服茶碱的比较
Thorax. 2006 Sep;61(9):761-6. doi: 10.1136/thx.200X.058156.
2
Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression.组蛋白脱乙酰酶2介导的糖皮质激素受体去乙酰化作用可抑制核因子κB。
J Exp Med. 2006 Jan 23;203(1):7-13. doi: 10.1084/jem.20050466. Epub 2005 Dec 27.
3
Theophylline in chronic obstructive pulmonary disease: new horizons.慢性阻塞性肺疾病中的茶碱：新视野
Proc Am Thorac Soc. 2005;2(4):334-9; discussion 340-1. doi: 10.1513/pats.200504-024SR.
4
Decreased histone deacetylase activity in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中组蛋白去乙酰化酶活性降低
N Engl J Med. 2005 May 12;352(19):1967-76. doi: 10.1056/NEJMoa041892.
5
Histone acetylation and deacetylation: importance in inflammatory lung diseases.组蛋白乙酰化与去乙酰化：在炎症性肺部疾病中的重要性
Eur Respir J. 2005 Mar;25(3):552-63. doi: 10.1183/09031936.05.00117504.
6
Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.茶碱可恢复慢性阻塞性肺疾病（COPD）巨噬细胞中的组蛋白脱乙酰酶活性及类固醇反应。
J Exp Med. 2004 Sep 6;200(5):689-95. doi: 10.1084/jem.20040416. Epub 2004 Aug 30.
7
Effect of low-dose theophylline on airway inflammation in COPD.低剂量茶碱对慢性阻塞性肺疾病气道炎症的影响。
Respirology. 2004 Jun;9(2):249-54. doi: 10.1111/j.1440-1843.2004.00573.x.
8
Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration.氧化应激降低组蛋白去乙酰化酶2的活性并增强白细胞介素-8基因的表达：酪氨酸硝化作用
Biochem Biophys Res Commun. 2004 Feb 27;315(1):240-5. doi: 10.1016/j.bbrc.2004.01.046.
9
Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.慢性阻塞性肺疾病中的皮质类固醇抵抗：组蛋白去乙酰化酶的失活
Lancet. 2004 Feb 28;363(9410):731-3. doi: 10.1016/S0140-6736(04)15650-X.
10
Theophylline: new perspectives for an old drug.茶碱：一种老药的新视角。
Am J Respir Crit Care Med. 2003 Mar 15;167(6):813-8. doi: 10.1164/rccm.200210-1142PP.
Zotero 插件